Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study
暂无分享,去创建一个
[1] G. Lee,et al. Clinical Outcomes following Endoscopic Treatment for Sporadic Nonampullary Duodenal Adenoma , 2020, Digestive Diseases.
[2] E. Verna,et al. Increased Prevalence of Colorectal Adenomas in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study , 2019, Digestive Diseases.
[3] H. Sørensen,et al. Prevalence of Colorectal Neoplasms and Mortality in New Users of Low-Dose Aspirin With Lower Gastrointestinal Bleeding. , 2019, American journal of therapeutics.
[4] Sigrun Alba Johannesdottir Schmidt,et al. The Danish health care system and epidemiological research: from health care contacts to database records , 2019, Clinical epidemiology.
[5] P. Myrcha,et al. Diabetes association of polyps and colon cancer. , 2019, Polski przeglad chirurgiczny.
[6] H. Brenner,et al. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial , 2019, JAMA.
[7] M. Bretthauer,et al. Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening. , 2019, Gastroenterology.
[8] A. Humphries,et al. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology , 2019, Gut.
[9] A. Dziki,et al. Preferences of patients with inflammatory bowel disease for receiving specialized health services using technology: the role of Internet and other sources of medical information. , 2019, Polski przeglad chirurgiczny.
[10] V. Beral,et al. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England , 2019, International journal of epidemiology.
[11] R. Collins,et al. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.
[12] D. Moga,et al. Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study , 2018, American Journal of Cardiovascular Drugs.
[13] Suzanne G. Orchard,et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly , 2018, The New England journal of medicine.
[14] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[15] H. Sørensen,et al. Sampling strategies for selecting general population comparison cohorts , 2018, Clinical epidemiology.
[16] J. Kobiela,et al. Statins and Colorectal Cancer - A Systematic Review. , 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[17] A. Cifu,et al. Management of Patients With Acute Lower Gastrointestinal Tract Bleeding. , 2018, JAMA.
[18] Umberto Ricardi,et al. Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why? , 2018, Virchows Archiv.
[19] M. Viswanathan,et al. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2017, JAMA.
[20] H. Coleman,et al. Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasms. , 2017, Best practice & research. Clinical gastroenterology.
[21] Mohammad Hossein Khosravi,et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[22] S. Chuah,et al. The risk of lower gastrointestinal bleeding in low‐dose aspirin users , 2017, Alimentary pharmacology & therapeutics.
[23] D. Lieberman,et al. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.
[24] S. Upala,et al. Risk of colorectal adenomas, advanced adenomas and cancer in patients with colonic diverticular disease: Systematic review and meta‐analysis , 2017, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[25] Shankun Liu,et al. The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials , 2016, Front. Pharmacol..
[26] D. Angiolillo,et al. Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus , 2016, Circulation.
[27] L. Strate,et al. A Prospective Study of Alcohol Consumption and Smoking and the Risk of Major Gastrointestinal Bleeding in Men , 2016, PloS one.
[28] P. Rothwell,et al. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies , 2016, PloS one.
[29] E. Whitlock,et al. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.
[30] H. Sørensen,et al. Lower Gastrointestinal Bleeding And Risk of Gastrointestinal Cancer , 2016, Clinical and Translational Gastroenterology.
[31] H. Sørensen,et al. Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps. , 2016, Gastroenterology.
[32] Sigrun Alba Johannesdottir Schmidt,et al. The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.
[33] R. Erichsen,et al. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk , 2015, Annals of Internal Medicine.
[34] E. Kuipers,et al. Colorectal cancer screening: a global overview of existing programmes , 2015, Gut.
[35] W. Leung,et al. Systematic review with meta‐analysis: the association between the use of calcium channel blockers and gastrointestinal bleeding , 2015, Alimentary pharmacology & therapeutics.
[36] S. Y. Lim,et al. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.
[37] Á. Lanas,et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[38] N. Cook,et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[39] J. Hallas,et al. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case–control study , 2014, Cancer medicine.
[40] Henrik Toft Sørensen,et al. The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.
[41] J. Hallas,et al. Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012 , 2014, Clinical epidemiology.
[42] M. Klemp,et al. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis , 2014, BMJ Open.
[43] J. Holmes,et al. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. , 2014, Journal of the National Cancer Institute.
[44] A. Freedman,et al. Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. population , 2014, Pharmacoepidemiology and drug safety.
[45] H. Sørensen,et al. Risk of Colorectal Cancer in Patients with Acute Myocardial Infarction and Stroke: A Nationwide Cohort Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[46] R. DuBois,et al. The role of anti-inflammatory drugs in colorectal cancer. , 2013, Annual review of medicine.
[47] Henrik Toft Sørensen,et al. Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions , 2012, Clinical epidemiology.
[48] G. Launoy,et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. – First Edition Faecal occult blood testing , 2012, Endoscopy.
[49] M. Thun,et al. The role of aspirin in cancer prevention , 2012, Nature Reviews Clinical Oncology.
[50] R. McNally,et al. Aspirin Users Attending for NHS Bowel Cancer Screening Have Less Colorectal Neoplasia: Chemoprevention or False-Positive Faecal Occult Blood Testing? , 2012, Digestion.
[51] R. Benamouzig,et al. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial , 2011, Gut.
[52] C. Pedersen,et al. The Danish Civil Registration System , 2011, Scandinavian journal of public health.
[53] Marianne Lundkjær Gjerstorff,et al. The Danish Cancer Registry , 2011, Scandinavian journal of public health.
[54] Timothy L Lash,et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients , 2011, BMC medical research methodology.
[55] H. Brenner,et al. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. , 2010, JAMA.
[56] H. Sørensen,et al. Neither long-term statin use nor atherosclerotic disease is associated with risk of colorectal cancer. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[57] J. Bond,et al. Fecal Occult Blood Test in Patients on Low-Dose Aspirin, Warfarin, Clopidogrel, or Non-steroidal Anti-inflammatory Drugs , 2010, Digestive Diseases and Sciences.
[58] D. Chang,et al. Coexistence between Carotid Artery Stenosis and Colorectal Adenomatous Polyps in Middle-Aged Men , 2009, Digestion.
[59] S. Klang,et al. Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants , 2009, The American Journal of Gastroenterology.
[60] Jeffrey S. Morris,et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. , 2007, JAMA.
[61] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[62] K. Lai,et al. Coexistence between colorectal cancer/adenoma and coronary artery disease: results from 1382 patients , 2006, Alimentary pharmacology & therapeutics.
[63] R. Steele,et al. Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[64] A. Tamakoshi,et al. Medical History of Circulatory Diseases and Colorectal Cancer Death in the JACC Study , 2005, Journal of epidemiology.
[65] J. Olsen,et al. Risk of Cancer in Patients Hospitalized With Fatty Liver: A Danish Cohort Study , 2003, Journal of clinical gastroenterology.
[66] G. Beck,et al. A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.
[67] Susan Halabi,et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. , 2003, The New England journal of medicine.
[68] B. Modan,et al. Selectively increased risk of cancer in men with coronary heart disease. , 2001, The American journal of cardiology.
[69] J. Olsen,et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin , 2000, American Journal of Gastroenterology.
[70] L Frank,et al. When an Entire Country Is a Cohort , 2000, Science.
[71] J. Olsen,et al. Cancer Risk of Patients Discharged with Acute Myocardial Infarct , 1998, Epidemiology.
[72] H. Storm,et al. The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.
[73] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[74] Y. C. Chen,et al. Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke. , 1987, Thrombosis research.
[75] David Evans,et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer , 2016 .
[76] Seth D. Crockett,et al. Sessile serrated adenomas: an evidence-based guide to management. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[77] M. Bissell. Low-Dose Aspirin Use and Performance of Immunochemical Fecal Occult Blood Tests , 2012 .
[78] D. Snover. Update on the serrated pathway to colorectal carcinoma. , 2011, Human pathology.
[79] K. Muir,et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. , 2008, Gastroenterology.
[80] D. Rex,et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. , 1997, Gastroenterology.
[81] B. Bjerregaard,et al. Clinical Epidemiology Dovepress Dovepress Existing Data Sources for Clinical Epidemiology: the Danish National Pathology Registry and Data Bank , 2022 .